These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11911039)

  • 1. Healthcare utilization patterns and risk adjustment under Taiwan's National Health Insurance system.
    Chang RE; Lin W; Hsieh CJ; Chiang TL
    J Formos Med Assoc; 2002 Jan; 101(1):52-9. PubMed ID: 11911039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of diagnosis-based risk adjustment models to predict individual health care expenditure under the National Health Insurance system in Taiwan.
    Chang RE; Lai CL
    J Formos Med Assoc; 2005 Dec; 104(12):883-90. PubMed ID: 16607444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a risk-adjusted capitation model based on principal inpatient diagnoses in Taiwan.
    Lin W; Chang RE; Hsieh CJ; Yaung CL; Chiang TL
    J Formos Med Assoc; 2003 Sep; 102(9):637-43. PubMed ID: 14625609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in-depth assessment of a diagnosis-based risk adjustment model based on national health insurance claims: the application of the Johns Hopkins Adjusted Clinical Group case-mix system in Taiwan.
    Chang HY; Weiner JP
    BMC Med; 2010 Jan; 8():7. PubMed ID: 20082689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in the persistence of health expenditures and the implications for the design of capitation payments in Taiwan.
    Ku LJ; Chiou MJ; Liu LF
    J Health Serv Res Policy; 2015 Jul; 20(3):146-53. PubMed ID: 25829410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of alternative risk adjustment measures for predictive modeling: high risk patient case finding using Taiwan's National Health Insurance claims.
    Chang HY; Lee WC; Weiner JP
    BMC Health Serv Res; 2010 Dec; 10():343. PubMed ID: 21172009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of morbidity trajectories on identifying high-cost cases: using Taiwan's National Health Insurance as an example.
    Chang HY
    J Public Health (Oxf); 2014 Jun; 36(2):300-7. PubMed ID: 23740662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying morbidity burdens and medical utilization of children with intellectual disabilities in Taiwan: a nationwide study using the ACG case-mix adjustment system.
    Lee WC; Chen TJ
    Res Dev Disabil; 2012; 33(4):1270-8. PubMed ID: 22502854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morbidity trajectories as predictors of utilization: multi-year disease patterns in Taiwan's national health insurance program.
    Chang HY; Clark JM; Weiner JP
    Med Care; 2011 Oct; 49(10):918-23. PubMed ID: 21577165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National health insurance expenditure for adult beneficiaries in Taiwan in their last year of life.
    Liu CN; Yang MC
    J Formos Med Assoc; 2002 Aug; 101(8):552-9. PubMed ID: 12440085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Explanatory ability of the ACG system regarding the utilization and expenditure of the national health insurance population in Taiwan--a 5-year analysis.
    Lee WC; Huang TP
    J Chin Med Assoc; 2008 Apr; 71(4):191-9. PubMed ID: 18436502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical services utilization and expenditure of obesity-related disorders in Taiwanese adults.
    Chu NF; Wang SC; Chang HY; Wu DM
    Value Health; 2010; 13(6):829-36. PubMed ID: 20825625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health care utilization and expenditures of persons with diabetes comorbid with anxiety disorder: a national population-based cohort study.
    Huang CJ; Chiu HC; Hsieh HM; Yen JY; Lee MH; Chang KP; Li CY; Lin CH
    Gen Hosp Psychiatry; 2015; 37(4):299-304. PubMed ID: 25936674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing health expenditure inflation under a single-payer system: Taiwan's National Health Insurance.
    Yip WC; Lee YC; Tsai SL; Chen B
    Soc Sci Med; 2019 Jul; 233():272-280. PubMed ID: 29548564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Out-of-pocket payment for medical care under Taiwan's National Health Insurance system.
    Chi C; Lee JL; Tsai SL; Chen WY
    Health Econ; 2008 Aug; 17(8):961-75. PubMed ID: 18004793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare utilization and expenditure analysis between individuals with intellectual disabilities and the general population in Taiwan: a population-based nationwide child and adolescent study.
    Chiang PH; Chang YC; Lin JD; Tung HJ; Lin LP; Hsu SW
    Res Dev Disabil; 2013 Sep; 34(9):2485-92. PubMed ID: 23751294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Household out-of-pocket medical expenditures and National Health Insurance in Taiwan: income and regional inequality.
    Chu TB; Liu TC; Chen CS; Tsai YW; Chiu WT
    BMC Health Serv Res; 2005 Sep; 5():60. PubMed ID: 16137336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of Taiwan's National Health Insurance on access and health status of the elderly.
    Chen L; Yip W; Chang MC; Lin HS; Lee SD; Chiu YL; Lin YH
    Health Econ; 2007 Mar; 16(3):223-42. PubMed ID: 16929478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of the financial burden to the National Health Insurance for patients with major cancers in Taiwan.
    Chu PC; Hwang JS; Wang JD; Chang YY
    J Formos Med Assoc; 2008 Jan; 107(1):54-63. PubMed ID: 18218578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic, pharmacy-based, and self-reported health measures in risk equalization models.
    Stam PJ; van Vliet RC; van de Ven WP
    Med Care; 2010 May; 48(5):448-57. PubMed ID: 20393368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.